PADI4 and neoplasm: Interestingly, NET inhibition was documented in a recipient animal model with an arginine deiminase 4 gene (the enzyme PAD4, vitally involved in mediating NETosis from neutrophils) deletion with a better response to ICB in these murine systems emerging vs. those who expressed PAD4 and demonstrated NETs in the tumor microenvironment [43].